Q2 2019 13F Holders as of 30 Jun 2019
-
Type / Class
-
Equity / COMMON STOCK
-
Total 13F shares
-
41,833,685
-
Share change
-
+2,470,089
-
Total reported value
-
$10,895,359,280
-
Put/Call ratio
-
211%
-
Price per share
-
$260.49
-
Number of holders
-
474
-
Value change
-
+$619,287,692
-
Number of buys
-
229
-
Number of sells
-
293
Institutional Holders of ABIOMED INC - COMMON STOCK (ABMD) as of Q2 2019
As of 30 Jun 2019,
ABIOMED INC - COMMON STOCK (ABMD) was held by
474 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
41,833,685 shares.
The largest 10 holders included
VANGUARD GROUP INC, BlackRock Inc., PRIMECAP MANAGEMENT CO/CA/, RENAISSANCE TECHNOLOGIES LLC, BAILLIE GIFFORD & CO, SANDS CAPITAL MANAGEMENT, LLC, STATE STREET CORP, BROWN CAPITAL MANAGEMENT LLC, WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC, and AMUNDI PIONEER ASSET MANAGEMENT INC.
This page lists
475
institutional shareholders reporting positions in this security
for the Q2 2019 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.